100 related articles for article (PubMed ID: 1633729)
21. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
22. [Hodgkin lymphomas ar negative with regard to bcl-2/JH gene rearrangement, but partly express BCL-2 protein: analysis of 83 cases from the German Hodgkin Trial].
Nolte M; Werner M; von Wasielewski R; Wilkens L; Fischer R; Hübner K; Georgii A
Verh Dtsch Ges Pathol; 1994; 78():329-33. PubMed ID: 7534007
[TBL] [Abstract][Full Text] [Related]
23. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
24. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas.
Pittaluga S; Ayoubi TA; Wlodarska I; Stul M; Cassiman JJ; Mecucci C; Van Den Berghe H; Van De Ven WJ; De Wolf-Peeters C
J Pathol; 1996 Jun; 179(2):145-50. PubMed ID: 8758205
[TBL] [Abstract][Full Text] [Related]
25. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
[TBL] [Abstract][Full Text] [Related]
26. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.
Pezzella F; Tse AG; Cordell JL; Pulford KA; Gatter KC; Mason DY
Am J Pathol; 1990 Aug; 137(2):225-32. PubMed ID: 2201196
[TBL] [Abstract][Full Text] [Related]
27. Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.
Steube KG; Jadau A; Teepe D; Drexler HG
Leukemia; 1995 Nov; 9(11):1841-6. PubMed ID: 7475272
[TBL] [Abstract][Full Text] [Related]
28. Bcl-6 protein expression in normal and neoplastic lymphoid tissues.
Falini B; Fizzotti M; Pileri S; Liso A; Pasqualucci L; Flenghi L
Ann Oncol; 1997; 8 Suppl 2():101-4. PubMed ID: 9209651
[TBL] [Abstract][Full Text] [Related]
29. Normal and neoplastic human plasma cells express bcl-2 antigen.
Hamilton MS; Barker HF; Ball J; Drew M; Abbot SD; Franklin IM
Leukemia; 1991 Sep; 5(9):768-71. PubMed ID: 1943229
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.
Flenghi L; Bigerna B; Fizzotti M; Venturi S; Pasqualucci L; Pileri S; Ye BH; Gambacorta M; Pacini R; Baroni CD; Pescarmona E; Anagnostopoulos I; Stein H; Asdrubali G; Martelli MF; Pelicci PG; Dalla-Favera R; Falini B
Am J Pathol; 1996 May; 148(5):1543-55. PubMed ID: 8623923
[TBL] [Abstract][Full Text] [Related]
31. Discordant morphologic features in bone marrow involvement by malignant lymphomas: use of gene rearrangement patterns for diagnosis.
Crisan D; Mattson JC
Am J Hematol; 1995 Aug; 49(4):299-309. PubMed ID: 7639275
[TBL] [Abstract][Full Text] [Related]
32. Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization.
Kondo E; Nakamura S; Onoue H; Matsuo Y; Yoshino T; Aoki H; Hayashi K; Takahashi K; Minowada J; Nomura S
Blood; 1992 Oct; 80(8):2044-51. PubMed ID: 1391959
[TBL] [Abstract][Full Text] [Related]
33. CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non-Hodgkin lymphoma.
Dakappagari N; Ho SN; Gascoyne RD; Ranuio J; Weng AP; Tangri S
Cytometry B Clin Cytom; 2012 Mar; 82(2):112-9. PubMed ID: 22076940
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte predominance Hodgkin's disease (nodular paragranuloma)--a bcl-2 negative germinal centre lymphoma.
Algara P; Martinez P; Sanchez L; Villuendas R; Orradre JL; Oliva H; Piris MA
Histopathology; 1991 Jul; 19(1):69-75. PubMed ID: 1916688
[TBL] [Abstract][Full Text] [Related]
35. Absence of bcl-2 expression by activated CD45RO+ T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death.
Tamaru Y; Miyawaki T; Iwai K; Tsuji T; Nibu R; Yachie A; Koizumi S; Taniguchi N
Blood; 1993 Jul; 82(2):521-7. PubMed ID: 8329707
[TBL] [Abstract][Full Text] [Related]
36. bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangements.
Papakonstantinou G; Verbeke C; Hastka J; Bohrer M; Hehlmann R
Br J Haematol; 2001 May; 113(2):383-90. PubMed ID: 11380403
[TBL] [Abstract][Full Text] [Related]
37. Expression of Bcl-2 protein and Bcl-2 mRNA in normal and neoplastic lymphoid tissues.
Akagi T; Kondo E; Yoshino T
Leuk Lymphoma; 1994 Mar; 13(1-2):81-7. PubMed ID: 8025526
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma.
Pezzella F; Morrison H; Jones M; Gatter KC; Lane D; Harris AL; Mason DY
Histopathology; 1993 Jan; 22(1):39-44. PubMed ID: 8436340
[TBL] [Abstract][Full Text] [Related]
39. Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues.
Chleq-Deschamps CM; LeBrun DP; Huie P; Besnier DP; Warnke RA; Sibley RK; Cleary ML
Blood; 1993 Jan; 81(2):293-8. PubMed ID: 8422456
[TBL] [Abstract][Full Text] [Related]
40. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes.
Yoshino T; Kondo E; Cao L; Takahashi K; Hayashi K; Nomura S; Akagi T
Blood; 1994 Apr; 83(7):1856-61. PubMed ID: 7511441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
